Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients: Author’s Reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Works matching IS 13075888 AND DT 2024 AND VI 5 AND IP 3
Results: 11
1
2
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
3
A brief communication of patients with homozygous C282Y mutation-related hereditary hemochromatosis.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 161, doi. 10.14744/hf.2024.2024.0020
- By:
- Publication type:
- Article
4
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 150, doi. 10.14744/hf.2023.2023.0028
- By:
- Publication type:
- Article
5
Comparison of the recommendation of international autoimmune hepatitis pathology group 2022 and the simplified criteria for autoimmune hepatitis 2008: A preliminary study.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 100, doi. 10.14744/hf.2023.2023.0061
- By:
- Publication type:
- Article
6
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 126, doi. 10.14744/hf.2023.2023.0042
- By:
- Publication type:
- Article
7
Comparison of triglyceride-glucose index and anthropometric obesity indices in predicting severe grades of hepatic steatosis in nonalcoholic fatty liver disease among non-diabetic obese individuals.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 113, doi. 10.14744/hf.2023.2023.0049
- By:
- Publication type:
- Article
8
The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in the Turkish population in HBV-related hepatocellular carcinoma.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 106, doi. 10.14744/hf.2023.2023.0054
- By:
- Publication type:
- Article
9
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 139, doi. 10.14744/hf.2023.2023.0025
- By:
- Publication type:
- Article
10
The evolution and revolution of artificial intelligence in hepatology: From current applications to future paradigms.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 97, doi. 10.14744/hf.2024.2024.ed0001
- By:
- Publication type:
- Article
11
Risk factors for relapse after discontinuation of tenofovir or entecavir in hepatitis B e antigen-negative patients.
- Published in:
- Hepatology Forum, 2024, v. 5, n. 3, p. 120, doi. 10.14744/hf.2023.2023.0060
- By:
- Publication type:
- Article